<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vestim</journal-id><journal-title-group><journal-title xml:lang="ru">Известия Национальной  академии наук Беларуси. Серия медицинских наук</journal-title><trans-title-group xml:lang="en"><trans-title>Proceedings of the National Academy of Sciences of Belarus, Medical series</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1814-6023</issn><issn pub-type="epub">2524-2350</issn><publisher><publisher-name>The Republican Unitary Enterprise Publishing House "Belaruskaya Navuka"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29235/1814-6023-2018-15-2-215-221</article-id><article-id custom-type="elpub" pub-id-type="custom">vestim-434</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ И ЭКСПЕРИМЕНТАЛЬНАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL AND EXPERIMENTAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>КАРДИОПРОТЕКТОРНАЯ ЭФФЕКТИВНОСТЬ ДИСТАНТНОГО ИШЕМИЧЕСКОГО ПРЕКОНДИЦИОНИРОВАНИЯ ПРИ ИШЕМИИ-РЕПЕРФУЗИИ МИОКАРДА У КРЫС  С ЭКСПЕРИМЕНТАЛЬНОЙ ДИСЛИПИДЕМИЕЙ</article-title><trans-title-group xml:lang="en"><trans-title>CARDIOPROTECTIVE EFFICIENCY OF REMOTE ISCHEMIC PRECONDITIONING  DURING ISCHEMIA-REPERFUSION IN RATS WITH EXPERIMENTAL DYSLIPIDEMIA</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Висмонт</surname><given-names>Ф. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Vismont</surname><given-names>F. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Висмонт Франтишек Иванович – член-корреспондент, д-р мед. наук, профессор, заведующий кафедрой.  </p><p>пр-т Дзержинского, 83, 220116, г. Минск.</p></bio><bio xml:lang="en"><p>Frantishek I. Vismont – Corresponding Member, D. Sc.  (Med.), Professor, Head of the Department.</p><p>83, Dzerzhinskiy Ave., 220116, Minsk.</p></bio><email xlink:type="simple">patfiz@bsmu.by</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чепелев</surname><given-names>С. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Chepelev</surname><given-names>S. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чепелев Сергей Николаевич – ассистент. </p><p>пр-т Дзержинского, 83, 220116, г. Минск.</p></bio><bio xml:lang="en"><p>Sergey  N. Chepelev – Assistant.</p><p>83, Dzerzhinskiy Ave., 220116, Minsk.</p></bio><email xlink:type="simple">drserge1991@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глебов</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Glebov</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Глебов Андрей Николаевич – канд. мед. наук, доцент.  </p><p>пр-т Дзержинского, 83, 220116, г. Минск.</p></bio><bio xml:lang="en"><p>Andrey N. Glebov – Ph. D. (Med.), Assistant Professor.  </p><p>83, Dzerzhinskiy Ave., 220116, Minsk.</p></bio><email xlink:type="simple">hlebauan@bsmu.by</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Висмонт</surname><given-names>А. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Vismont</surname><given-names>A. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Висмонт Арвид Франтишкович – канд. мед. наук,  ст. науч. сотрудник. </p><p>пр-т Дзержинского, 83, 220116, г. Минск.</p></bio><bio xml:lang="en"><p>Arvid F. Vismont – Ph. D. (Med.),  Senior researcher. </p><p>83, Dzerzhinskiy Ave., 220116, Minsk.</p></bio><email xlink:type="simple">patfiz@bsmu.by</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Юшкевич</surname><given-names>П. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Jushkevich</surname><given-names>P. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Юшкевич Павел Францевич – канд. мед. наук, ассистент.</p><p>пр-т Дзержинского, 83, 220116, г. Минск.</p></bio><bio xml:lang="en"><p>Pavel F. Jushkevich – Ph. D. (Med.),  Assistant. </p><p>83, Dzerzhinskiy Ave., 220116, Minsk.</p></bio><email xlink:type="simple">patfiz@bsmu.by</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Белорусский государственный медицинский университет.</institution></aff><aff xml:lang="en"><institution>Belarusian State  Medical University.</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>25</day><month>06</month><year>2018</year></pub-date><volume>15</volume><issue>2</issue><fpage>215</fpage><lpage>221</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Висмонт Ф.И., Чепелев С.Н., Глебов А.Н., Висмонт А.Ф., Юшкевич П.Ф., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Висмонт Ф.И., Чепелев С.Н., Глебов А.Н., Висмонт А.Ф., Юшкевич П.Ф.</copyright-holder><copyright-holder xml:lang="en">Vismont F.I., Chepelev S.N., Glebov A.N., Vismont A.F., Jushkevich P.F.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vestimed.belnauka.by/jour/article/view/434">https://vestimed.belnauka.by/jour/article/view/434</self-uri><abstract><p>Поиск новых эффективных методов предотвращения или ослабления ишемического повреждения  миокарда и механизмов их реализации является актуальной задачей современной экспериментальной и клинической  медицины и важным направлением исследований в физиологии.  Целью исследования было выявление воспроизводимости противоишемического и антиаритмического эффектов дистантного ишемического прекондиционирования (ДИПК)  миокарда у крыс с экспериментальной дислипидемией (ДЛЕ). Установлено, что ДИПК не эффективно в плане ограничения размеров зоны некроза в миокарде левого  желудочка при ишемии-реперфузии миокарда у крыс с ДЛЕ. В то же время после воспроизведения ДИПК у крыс с ДЛЕ имеет место выраженный антиаритмический эффект, о чем свидетельствует снижение длительности ишемических нарушений сердечного ритма на 85 % (p &lt; 0,05). Полученные данные дают основание говорить о необходи&lt; 0,05). Полученные данные дают основание говорить о необходи 0,05). Полученные данные дают основание говорить о необходи0,05). Полученные данные дают основание говорить о необходимости дифференцированного подхода к назначению ДИПК пациентам с острым инфарктом миокарда. Наличие такого фактора риска сердечно-сосудистых заболеваний, как ДЛЕ, может служить критерием для исключения ДИПК  в качестве способа уменьшения ишемических и реперфузионных повреждений миокарда у пациентов с острым инфарктом миокарда.</p></abstract><trans-abstract xml:lang="en"><p>The search for new effective methods of preventing or reducing ischemic myocardial injury and its mechanisms of realization is an actual problem of modern experimental and clinical medicine. The aim of the study was to determine the reproducibility of antiischemic and antiarrhythmic effects of the remote ischemic preconditioning myocardium of rats with dysrlipidemia (DLE). It was found that remote ischemic preconditioning is not  effective in terms of necrosis zone size limits in the left ventricle during ischemia-reperfusion in rats with DLE. At the same  time, after the reproduction of remote ischemic preconditioning in rats with DLE, a pronounced antiarrhythmic effect takes  place, as evidenced the decrease in the duration of ischemic heart rhythm disturbances by 85 % (p &lt; 0.05). The findings  indicate the need for a differentiated approach to the appointment of remote ischemic preconditioning in patients with acute  myocardial infarction. The existence of such a risk factor for cardiovascular diseases such as DLE can be a criterion for  exclusion remote ischemic preconditioning as a way of reducing ischemic and reperfusion injury of the myocardium in  patients with acute myocardial infarction.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>противоишемический эффект</kwd><kwd> антиаритмический эффект</kwd><kwd> дистантное ишемическое прекондиционирование</kwd><kwd> дислипидемия</kwd><kwd> зона риска</kwd><kwd> зона некроза</kwd></kwd-group><kwd-group xml:lang="en"><kwd> antiischemic effect</kwd><kwd> antiarrhythmic effect</kwd><kwd> remote ischemic preconditioning</kwd><kwd> dyslipidemia</kwd><kwd> risk zone</kwd><kwd> necrosis zone </kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Сердечно-сосудистые заболевания в Республике Беларусь: анализ ситуации и стратегии контроля / А. Г. Мрочек [и др.]. – Минск : Беларус. навука, 2011. – 341 с.</mixed-citation><mixed-citation xml:lang="en">Mrochek A. G., Grakovich A. A., Kozlov I. D., Gorbachev V. V. Cardiovascular diseases in the Republic of Belarus: the analysis of the situation and control strategy. Minsk, Belaruskaya navuka Publ., 2011. 341 p. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Шляхто, Е. В. Ограничение ишемического и реперфузионного повреждения миокарда с помощью пре- и посткондиционирования: молекулярные механизмы и мишени для фармакотерапии / Е. В. Шляхто, Е. М. Нифонтов, М. М. Галагудза // Креатив. кардиология. – 2007. – № 1–2. – С. 75–101.</mixed-citation><mixed-citation xml:lang="en">Shlyakhto E. V., Nifontov E. M., Galagudza M. M. Limitation of ischemic and reperfusion injury of the myocardium  using pre- and postconditioning: molecular mechanisms and targets for pharmacotherapy. Kreativnaya kardiologiya [Creative  Cardiology], 2007, no. 1-2, pp. 75-101 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Cokkinos, D. V. Myocardial protection in man – from research concept to clinical practice / D. V. Cokkinos, C. Pantos // Heart Failure Rev. – 2007. – Vol. 12, N 3–4. – P. 345–362. DOI: 10.1007/s10741-007-9030-5</mixed-citation><mixed-citation xml:lang="en">Cokkinos D. V., Pantos C. Myocardial protection in man - from research concept to clinical practice.  Heart Failure Reviews, 2007, vol. 12, no. 3-4, pp. 345-362. DOI: 10.1007/s10741-007-9030-5</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Любимов, А. В. Ишемия, реперфузия и прекондиционирование: традиционные и новые подходы в лечении инфаркта миокарда / А. В. Любимов, П. Д. Шабанов // Обзоры по клин. фармакологии и лекарств. терапии. – 2016. – Т. 14, № 3. – С. 3–11.</mixed-citation><mixed-citation xml:lang="en">Lyubimov A. V., Shabanov P. D. Ischemia, reperfusion and preconditioning: traditional and new approaches in the  treatment of myocardial infarction. Obzory po klinicheskoi farmakologii i lekarstvennoi terapii [Reviews of Clinical Pharmacology and Drug Therapy], 2016, vol. 14, no. 3, pp. 3-11 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Remote ischaemic pre- and delayed postconditioning – similar degree of cardioprotection but distinct mechanisms / М. Basalai [et al.] // Experimental Physiology. – 2012. – Vol. 97, N 8. – P. 908–917. DOI: 10.1113/expphysiol.2012.064923</mixed-citation><mixed-citation xml:lang="en">Basalay M., Barsukevich V., Mastitskaya S., Mrochek A., Pernow J., Sjöquist P.-O., Ackland G. L., Gourine A. V.,  Gourine A. Remote ischaemic pre- and delayed postconditioning - similar degree of  cardioprotection but distinct mechanisms. Experimental Physiology, 2012, vol. 97, no. 8, pp. 908-917. DOI: 10.1113/expphysiol.2012.064923</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Липовецкий, Б. М. Дислипидемии, атеросклероз и их связь с ишемической болезнью сердца и мозга / Б. М. Липовецкий. – СПб. : Эко-Вектор, 2012. – 79 с.</mixed-citation><mixed-citation xml:lang="en">Lipovetskii B. M. Dyslipidemia, atherosclerosis and their association with coronary heart disease and the brain. St.  Petersburg, Eko-Vektor Publ., 2012. 79 p. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cholesterol diet leads to attenuation of ischemic preconditioning-induced cardiac protection: the role of connexin 43 / А. Görbe [et al.] // Amer. J. of Physiology-Heart and Circulatory Physiology. – 2011. – Vol. 300, N 5. – P. H1907–H1913. DOI: 10.1152/ajpheart.01242.2010</mixed-citation><mixed-citation xml:lang="en">Görbe A., Varga Z. V., Kupai K., Bencsik P., Kocsis G. F., Csont T., Boengler K., Schulz R., Ferdinandy P. Cholesterol  diet leads to attenuation of ischemic preconditioning-induced cardiac protection: the role of connexin 43. American Journal of Physiology. Heart and Circulatory Physiology, 2011, vol. 300, no. 5, pp. H1907-H1913. DOI: 10.1152/ajpheart.01242.2010</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">The loss of pacing-induced preconditioning in atherosclerotic rabbits: role of hypercholesterolemia / Z. Szilvassy [et al.] // J. of Molecular and Cellular Cardiology. – 1995. – Vol. 27, N 12. – P. 2559–2569. DOI: 10.1006/jmcc.1995.0043</mixed-citation><mixed-citation xml:lang="en">Szilvassy Z., Ferdinandy P. Szilvassy J., Nagy I., Karcsu S., Lonovics J., Dux L., Koltai M. The loss of pacing-induced  preconditioning in atherosclerotic rabbits: role of hypercholesterolemia. Journal of Molecular and Cellular Cardiology, 1995,  vol. 27, no. 12, pp. 2559-2569. DOI: 10.1006/jmcc.1995.0043</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Preconditioning limits myocardial infarct size in hypercholesterolemic rabbits / D. T. Kremastinos [et al.] // Atherosclerosis. – 2000. – Vol. 150, N 1. – P. 81–89. DOI: 10.1016/s0021-9150(99)00389-5</mixed-citation><mixed-citation xml:lang="en">Kremastinos D. T., Bofilis E., Karavolias G. K., Papalois A., Kaklamanis L., Iliodromitis E. K. Preconditioning limits  myocardial infarct size in hypercholesterolemic rabbit.  Atherosclerosis, 2000, vol. 150, no. 1, pp. 81-89. DOI: 10.1016/s00219150(99)00389-5</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Моделирование постинфарктной сердечной недостаточности путем окклюзии левой коронарной артерии у крыс: техника и методы морфофункциональной оценки / А. А. Карпов [и др.] // Биомедицина. – 2014. – Т. 1, № 3. – С. 32–48.</mixed-citation><mixed-citation xml:lang="en">Karpov A. A., Ivkin D. Yu., Dracheva A. V., Pitukhina N. N., Uspenskaya Yu. K., Vaulina D. D., Uskov I. S., Eivazova Sh. D., Minasyan S. M., Vlasov T. D., Buryakina A. V., Galagudza M. M. Modeling of postinfarction heart failure by occlusion of the left coronary artery in rats: technique and methods of morphofunctional evaluation. Biomeditsina [Biomedicine], 2014, vol. 1, no. 3, pp. 32-48 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size / C. Clark [et al.] // J. of Pharmacological Methods. – 1980. – Vol. 3, N 4. – P. 357–368. DOI: 10.1016/0160-5402(80)90077-7</mixed-citation><mixed-citation xml:lang="en">Clark C., Foreman M. I., Kane K. A., McDonald F. M., Parratt J. R. Coronary artery ligation in anesthetized rats as  a method for the production of experimental dysrhythmias and for the determination of infarct size. Journal of Pharmacological Methods, 1980, vol. 3, no. 4, pp. 357-368. DOI: 10.1016/0160-5402(80)90077-7</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ischemic preconditioning and infarct mass: the effect of hypercholesterolemia and endothelial dysfunction / O. Jung [et al.] // Clinical and Experimental Hypertension. – 2000. – Vol. 22, N 2. – P. 165–179. DOI: 10.1081/ceh-100100070</mixed-citation><mixed-citation xml:lang="en">Jung O., Jung W., Malinski T., Wiemer G., Schoelkens B. A., Linz W. Ischemic preconditioning and infarct mass: the  effect of hypercholesterolemia and endothelial dysfunction. Clinical and Experimental Hypertension, 2000, vol. 22, no. 2,  pp. 165–179. DOI: 10.1081/ceh-100100070</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hypercholesterolemia abrogates the cardioprotection of ischemic postconditioning in isolated rat heart: roles of glycogen synthase kinase-3β and the mitochondrial permeability transition pore / N. Wu [et al.] // Cell Biochemistry and Biophysics. – 2014. – Vol. 69, N 1. – P. 123–130. DOI: 10.1007/s12013-013-9778-2</mixed-citation><mixed-citation xml:lang="en">Wu N., Zhang X., Guan Y., Shu W., Jia P., Jia D. Hypercholesterolemia abrogates the cardioprotection of ischemic  postconditioning in isolated rat heart: roles of glycogen synthase kinase-3β and the mitochondrial permeability transition  pore. Cell Biochemistry and Biophysics, 2014, vol. 69, no. 1, pp. 123-130. DOI: 10.1007/s12013-013-9778-2</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ferdinandy, P. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning and postconditioning / P. Ferdinandy, R. Schulz, G. Baxter // Pharmacological Rev. – 2007. – Vol. 59, N 4. – P. 418–458. DOI: 10.1124/pr.107.06002</mixed-citation><mixed-citation xml:lang="en">Ferdinandy P., Schulz R., Baxter G. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury,  preconditioning and postconditioning. Pharmacological Reviews, 2007, vol. 59, no. 4, pp. 418-458. DOI: 10.1124/pr.107.06002</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Самойлов, М. О. Сигнальные молекулярные и гормональные механизмы формирования протективных эффектов гипоксического прекондиционирования / М. О. Самойлов, Е. А. Рыбникова, А. В. Чурилова // Патол. физиология и эксперим. терапия. – 2012. – № 3. – С. 3–10.</mixed-citation><mixed-citation xml:lang="en">Samoilov M. O., Rybnikova E. A., Churilova A. V. Signal molecular and hormonal mechanisms of the protective effect of hypoxic preconditioning. Patologicheskaya fiziologiya i eksperimental’naya terapiya [Pathological Physiology and  Experimental Therapy], 2012, no. 3, pp. 3-10 (in Russian).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
